Skip to main content
. 2022 May 19;14(5):1088. doi: 10.3390/pharmaceutics14051088

Figure 8.

Figure 8

Quantitative estimation of mAb (anti-IL10) structure/function after PEG5000–Ad conjugation. Positive controls (according to MabTag protocol, using unmodified primary antibodies) were assumed to have 100% antigen recognition.